Related Experiment Video

Updated: May 12, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Inpp4b is a novel negative modulator of osteoclast differentiation and a prognostic locus for human osteoporosis

Jean Vacher1

  • 1Clinical Research Institute of Montreal, Départment de Médecine, Université de Montréal, Department of Medicine, McGill University, Montréal, Québec, Canada. vacherj@ircm.qc.ca

Annals of the New York Academy of Sciences
|April 5, 2013
PubMed

Insights

Inositol polyphosphate 4-phosphatase type II (Inpp4b) negatively regulates osteoclast formation, offering a new target for osteoporosis treatment. Understanding its role in bone cell signaling is key to developing therapies for this common bone disease.

Area of Science:

  • Bone Biology
  • Cell Signaling
  • Osteoporosis Research

Background:

  • Osteoporosis is a major public health concern characterized by low bone mass and microarchitectural deterioration.
  • Osteoclast and osteoblast differentiation and activation are tightly regulated processes crucial for bone homeostasis.
  • Inositol polyphosphate 4-phosphatase type II (Inpp4b) has emerged as a significant factor in bone metabolism.

Purpose of the Study:

  • To summarize the known cellular and molecular mechanisms controlling osteoclast and osteoblast differentiation.
  • To highlight the role of Inpp4b as a negative modulator of osteoclast differentiation.
  • To discuss the crosstalk signaling pathways involved in bone cell regulation.

Main Methods:

  • Literature review of cellular and molecular mechanisms.
  • Analysis of signaling pathways in osteoclast and osteoblast differentiation.
  • Examination of Inpp4b's function and prognostic value.

Main Results:

  • Inpp4b acts as a novel negative regulator of osteoclast differentiation.
  • Inpp4b is identified as a prognostic locus for human osteoporosis.
  • Key cellular, molecular, and crosstalk signaling mechanisms governing bone cell activity are elucidated.

Conclusions:

  • Inpp4b plays a critical role in maintaining bone health by inhibiting osteoclast differentiation.
  • Targeting Inpp4b may offer a therapeutic strategy for osteoporosis.
  • Further research into Inpp4b-mediated signaling pathways is warranted for developing novel osteoporosis treatments.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...